Cargando…
The Anticancer Effects of the Pro-Apoptotic Benzofuran-Isatin Conjugate (5a) Are Associated With p53 Upregulation and Enhancement of Conventional Chemotherapeutic Drug Efficiency in Colorectal Cancer Cell Lines
The present study aimed to investigate in-depth a cytotoxic novel benzofuran-isatin conjugate (5a, 3-methyl-N'-(2-oxoindolin-3-ylidene)benzofuran-2-carbohydrazide) with promising potential anticancer activities in colorectal adenocarcinoma HT29 and metastatic colorectal cancer (CRC) SW620 cell...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421242/ https://www.ncbi.nlm.nih.gov/pubmed/36046830 http://dx.doi.org/10.3389/fphar.2022.923398 |
_version_ | 1784777553162010624 |
---|---|
author | Vaali-Mohammed, Mansoor-Ali Abdulla, Maha-Hamadien Matou-Nasri, Sabine Eldehna, Wagdy M. Meeramaideen, M. Elkaeed, Eslam B. El-Watidy, Mohammed Alhassan, Noura S. Alkhaya, Khayal Al Obeed, Omar |
author_facet | Vaali-Mohammed, Mansoor-Ali Abdulla, Maha-Hamadien Matou-Nasri, Sabine Eldehna, Wagdy M. Meeramaideen, M. Elkaeed, Eslam B. El-Watidy, Mohammed Alhassan, Noura S. Alkhaya, Khayal Al Obeed, Omar |
author_sort | Vaali-Mohammed, Mansoor-Ali |
collection | PubMed |
description | The present study aimed to investigate in-depth a cytotoxic novel benzofuran-isatin conjugate (5a, 3-methyl-N'-(2-oxoindolin-3-ylidene)benzofuran-2-carbohydrazide) with promising potential anticancer activities in colorectal adenocarcinoma HT29 and metastatic colorectal cancer (CRC) SW620 cell lines. Thus, the primary cell events involved in tumorigenicity, tumor development, metastasis, and chemotherapy response were explored. Both CRC cell lines were exposed to different concentrations of Compound 5a and then subjected to real-time cell viability, migration, and invasion assays, colony formation and cytotoxicity assays, and flow cytometry for cell cycle analysis and apoptosis determination. Western blot and RT-qPCR were performed to assess the protein and transcript expression levels of epithelial-mesenchymal transition (EMT), cell cycle, and apoptosis markers. We showed that the Compound 5a treatment exhibited anticancer effects through inhibition of HT29 and SW620 cell viability, migration, and invasion, in a dose-dependent manner, which were associated with the upregulation of the tumor suppressor p53. Compound 5a also inhibited the colony formation ability of HT29 and SW620 cells and reversed EMT markers E-cadherin and N-cadherin expression. CRC cell exposure to Compound 5a resulted in a cell cycle arrest at the G1/G0 phase in HT29 cells and at the G2/M phase in SW620 cells, along with the downregulation of cyclin A1 expression, described to be involved in the S phase entry. Furthermore, Compound 5a-induced apoptosis was associated with the downregulation of the anti-apoptotic Bcl-xl marker, upregulation of pro-apoptotic Bax and cytochrome c markers, and increased mitochondrial outer membrane permeability, suggesting the involvement of mitochondria-dependent apoptosis pathway. In addition, the combination studies of Compound 5a with the main conventional chemotherapeutic drugs 5-fluorouracil, irinotecan, and oxaliplatin showed a more potent cytotoxic effect in both CRC cells than a single treatment. In conclusion, our findings described the interesting in vitro anticancer properties of Compound 5a, shown to have possible antitumor, antimetastatic, and pro-apoptotic activities, with the enhancement of the cytotoxic efficiency of conventional chemotherapeutic drugs. In vivo studies are requested to confirm the promising anticancer potential of Compound 5a for CRC therapy. |
format | Online Article Text |
id | pubmed-9421242 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94212422022-08-30 The Anticancer Effects of the Pro-Apoptotic Benzofuran-Isatin Conjugate (5a) Are Associated With p53 Upregulation and Enhancement of Conventional Chemotherapeutic Drug Efficiency in Colorectal Cancer Cell Lines Vaali-Mohammed, Mansoor-Ali Abdulla, Maha-Hamadien Matou-Nasri, Sabine Eldehna, Wagdy M. Meeramaideen, M. Elkaeed, Eslam B. El-Watidy, Mohammed Alhassan, Noura S. Alkhaya, Khayal Al Obeed, Omar Front Pharmacol Pharmacology The present study aimed to investigate in-depth a cytotoxic novel benzofuran-isatin conjugate (5a, 3-methyl-N'-(2-oxoindolin-3-ylidene)benzofuran-2-carbohydrazide) with promising potential anticancer activities in colorectal adenocarcinoma HT29 and metastatic colorectal cancer (CRC) SW620 cell lines. Thus, the primary cell events involved in tumorigenicity, tumor development, metastasis, and chemotherapy response were explored. Both CRC cell lines were exposed to different concentrations of Compound 5a and then subjected to real-time cell viability, migration, and invasion assays, colony formation and cytotoxicity assays, and flow cytometry for cell cycle analysis and apoptosis determination. Western blot and RT-qPCR were performed to assess the protein and transcript expression levels of epithelial-mesenchymal transition (EMT), cell cycle, and apoptosis markers. We showed that the Compound 5a treatment exhibited anticancer effects through inhibition of HT29 and SW620 cell viability, migration, and invasion, in a dose-dependent manner, which were associated with the upregulation of the tumor suppressor p53. Compound 5a also inhibited the colony formation ability of HT29 and SW620 cells and reversed EMT markers E-cadherin and N-cadherin expression. CRC cell exposure to Compound 5a resulted in a cell cycle arrest at the G1/G0 phase in HT29 cells and at the G2/M phase in SW620 cells, along with the downregulation of cyclin A1 expression, described to be involved in the S phase entry. Furthermore, Compound 5a-induced apoptosis was associated with the downregulation of the anti-apoptotic Bcl-xl marker, upregulation of pro-apoptotic Bax and cytochrome c markers, and increased mitochondrial outer membrane permeability, suggesting the involvement of mitochondria-dependent apoptosis pathway. In addition, the combination studies of Compound 5a with the main conventional chemotherapeutic drugs 5-fluorouracil, irinotecan, and oxaliplatin showed a more potent cytotoxic effect in both CRC cells than a single treatment. In conclusion, our findings described the interesting in vitro anticancer properties of Compound 5a, shown to have possible antitumor, antimetastatic, and pro-apoptotic activities, with the enhancement of the cytotoxic efficiency of conventional chemotherapeutic drugs. In vivo studies are requested to confirm the promising anticancer potential of Compound 5a for CRC therapy. Frontiers Media S.A. 2022-08-15 /pmc/articles/PMC9421242/ /pubmed/36046830 http://dx.doi.org/10.3389/fphar.2022.923398 Text en Copyright © 2022 Vaali-Mohammed, Abdulla, Matou-Nasri, Eldehna, Meeramaideen, Elkaeed, El-Watidy, Alhassan, Alkhaya and Al Obeed. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Vaali-Mohammed, Mansoor-Ali Abdulla, Maha-Hamadien Matou-Nasri, Sabine Eldehna, Wagdy M. Meeramaideen, M. Elkaeed, Eslam B. El-Watidy, Mohammed Alhassan, Noura S. Alkhaya, Khayal Al Obeed, Omar The Anticancer Effects of the Pro-Apoptotic Benzofuran-Isatin Conjugate (5a) Are Associated With p53 Upregulation and Enhancement of Conventional Chemotherapeutic Drug Efficiency in Colorectal Cancer Cell Lines |
title | The Anticancer Effects of the Pro-Apoptotic Benzofuran-Isatin Conjugate (5a) Are Associated With p53 Upregulation and Enhancement of Conventional Chemotherapeutic Drug Efficiency in Colorectal Cancer Cell Lines |
title_full | The Anticancer Effects of the Pro-Apoptotic Benzofuran-Isatin Conjugate (5a) Are Associated With p53 Upregulation and Enhancement of Conventional Chemotherapeutic Drug Efficiency in Colorectal Cancer Cell Lines |
title_fullStr | The Anticancer Effects of the Pro-Apoptotic Benzofuran-Isatin Conjugate (5a) Are Associated With p53 Upregulation and Enhancement of Conventional Chemotherapeutic Drug Efficiency in Colorectal Cancer Cell Lines |
title_full_unstemmed | The Anticancer Effects of the Pro-Apoptotic Benzofuran-Isatin Conjugate (5a) Are Associated With p53 Upregulation and Enhancement of Conventional Chemotherapeutic Drug Efficiency in Colorectal Cancer Cell Lines |
title_short | The Anticancer Effects of the Pro-Apoptotic Benzofuran-Isatin Conjugate (5a) Are Associated With p53 Upregulation and Enhancement of Conventional Chemotherapeutic Drug Efficiency in Colorectal Cancer Cell Lines |
title_sort | anticancer effects of the pro-apoptotic benzofuran-isatin conjugate (5a) are associated with p53 upregulation and enhancement of conventional chemotherapeutic drug efficiency in colorectal cancer cell lines |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421242/ https://www.ncbi.nlm.nih.gov/pubmed/36046830 http://dx.doi.org/10.3389/fphar.2022.923398 |
work_keys_str_mv | AT vaalimohammedmansoorali theanticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT abdullamahahamadien theanticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT matounasrisabine theanticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT eldehnawagdym theanticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT meeramaideenm theanticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT elkaeedeslamb theanticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT elwatidymohammed theanticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT alhassannouras theanticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT alkhayakhayal theanticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT alobeedomar theanticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT vaalimohammedmansoorali anticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT abdullamahahamadien anticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT matounasrisabine anticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT eldehnawagdym anticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT meeramaideenm anticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT elkaeedeslamb anticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT elwatidymohammed anticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT alhassannouras anticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT alkhayakhayal anticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines AT alobeedomar anticancereffectsoftheproapoptoticbenzofuranisatinconjugate5aareassociatedwithp53upregulationandenhancementofconventionalchemotherapeuticdrugefficiencyincolorectalcancercelllines |